Bernard-Soulier Disease (BSS) is a rare inherited bleeding disorder caused by a deficiency or dysfunction of the platelet surface receptors, particularly glycoprotein (GP) Ib-IX-V complex, which plays a critical role in platelet adhesion and aggregation during blood clot formation. The defect in these platelet receptors leads to impaired platelet function, resulting in bleeding tendencies and impaired clot formation.
BSS is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the defective gene (one from each parent) to develop the disease. It was first described in the 1940s by French scientists Bernard and Soulier, hence the name.
Bernard-Soulier Disease (BSS) is a rare, inherited bleeding disorder characterized by large platelets and a low platelet count (thrombocytopenia). This condition affects the blood’s ability to clot properly, leading to excessive bleeding and easy bruising. Named after Drs. Jean Bernard and Jean-Pierre Soulier, this disorder requires specialized care to manage its symptoms effectively.
Bernard-Soulier Disease is caused by a genetic mutation that affects the GPIb-IX-V complex on the surface of platelets. This complex plays a crucial role in platelet adhesion during the blood clotting process. Since BSS is inherited, individuals with this disease have two faulty copies of the gene (one from each parent). If both parents are carriers, there’s a 25% chance their child will inherit the disease.
There are three main types of Bernard-Soulier Disease:
People with Bernard-Soulier Disease may experience a variety of symptoms, including:
Diagnosis of Bernard-Soulier Disease typically involves a combination of clinical examination, family history, and specialized blood tests. The most common diagnostic methods include:
Currently, there is no cure for Bernard-Soulier Disease, but various treatment options help manage symptoms and reduce the risk of bleeding:
The cost of treating Bernard-Soulier Disease in India is relatively affordable compared to many Western countries, making it a viable option for patients seeking quality care. The total cost of treatment depends on the severity of the disease, the required treatments, and the duration of care. Here’s an overview of the costs:
Initial Consultation:
USD: $30 – $100
INR: ₹2,200 – ₹7,400
Blood Tests (CBC, Platelet Function Tests, Genetic Testing, etc.):
USD: $50 – $200
INR: ₹3,700 – ₹14,800
Platelet Transfusions (per session):
USD: $200 – $500
INR: ₹15,000 – ₹37,000
Desmopressin (DDAVP) Treatment:
USD: $50 – $150
INR: ₹3,700 – ₹11,000 per month
Antifibrinolytic Therapy (per month):
USD: $100 – $300
INR: ₹7,400 – ₹22,200
Hospital Stay (per night):
USD: $25 – $200
INR: ₹2,000 – ₹15,000
India offers affordable medical care with specialized treatments for Bernard-Soulier Disease, making it an attractive option for patients seeking cost-effective solutions while ensuring high-quality care. The costs are significantly lower than in many Western countries without compromising on treatment standards.